Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
137 studies found for:    "Leiomyosarcoma"
Show Display Options
Rank Status Study
1 Recruiting Efficacy of Gemcitabine With Pazopanib as Second Line Treatment in Patients With Metastatic or Relapsed Uterine or Soft Tissue Leiomyosarcomas
Condition: Leiomyosarcoma
Intervention: Drug: pazopanib + gemcitabine
2 Active, not recruiting Activity of Trabectedin or Gemcitabine + Docetaxel in Uterine Leiomyosarcoma
Condition: Leiomyosarcoma
Interventions: Drug: gemcitabine + docetaxel;   Drug: trabectedin
3 Completed
Has Results
Letrozole in Women With Advanced Estrogen/Progesterone Receptor Positive Uterine Leiomyosarcoma
Condition: Leiomyosarcoma
Intervention: Drug: letrozole
4 Withdrawn Pazopanib for Treating Uterine Leiomyosarcoma
Condition: Uterine Leiomyosarcoma
Intervention: Drug: Pazopanib
5 Active, not recruiting SARC018: A Study of Mocetinostat and Gemcitabine in Patients With Metastatic Leiomyosarcoma
Condition: Metastatic Leiomyosarcoma
Interventions: Drug: Mocetinostat;   Drug: Gemcitabine
6 Suspended Nivolumab Alone or in Combination With Ipilimumab in Treating Patients With Advanced Uterine Leiomyosarcoma
Condition: Uterine Corpus Leiomyosarcoma
Interventions: Biological: Ipilimumab;   Other: Laboratory Biomarker Analysis;   Biological: Nivolumab
7 Completed Study of Doxorubicin and Trabectedin in First Line Treatment on Patients With Metastatic Leiomyosarcoma
Conditions: Uterus Leiomyosarcoma;   Soft Tissue Leiomyosarcoma
Interventions: Drug: Doxorubicin;   Drug: Trabectedin
8 Recruiting Efficacy Study on Trabectedin in Retroperitoneal Leiomyosarcoma and Well Differentiated/Dedifferentiated Liposarcoma
Conditions: Liposarcoma;   Leiomyosarcoma
Intervention: Drug: Trabectedin
9 Not yet recruiting Study Comparing Efficacy of Doxorubicin With Trabectedin Followed by Trabectedin Versus Doxorubicine in Patients With Leiomyosarcoma
Condition: Uterine or Soft Tissue Leiomyosarcoma
Interventions: Drug: Doxorubicin;   Drug: Trabectedin
10 Completed
Has Results
A Study of Trabectedin or Dacarbazine for the Treatment of Patients With Advanced Liposarcoma or Leiomyosarcoma
Condition: Advanced Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
11 Unknown  Pazopanib vs. Pazopanib Plus Gemcitabine in Patients With Relapsed or Metastatic Uterine Leiomyosarcomas or Uterine Carcinosarcomas: a Multi-center, Randomized Phase-II Clinical Trial of the NOGGO and AGO - PazoDoble -
Condition: Relapsed or Metastatic Uterine Leiomyosarcomas or Carcinosarcomas
Interventions: Drug: Pazopanib plus Gemcitabine;   Drug: Pazopanib
12 Active, not recruiting A Study of Trabectedin (YONDELIS) in Patients With Locally Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Condition: Advanced or Metastatic Liposarcoma or Leiomyosarcoma
Interventions: Drug: Trabectedin;   Drug: Dacarbazine
13 Completed
Has Results
Adjuvant Chemotherapy for High Risk Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: gemcitabine, docetaxel, doxorubicin
14 Active, not recruiting Letrozole Versus Observation in Patients With Newly Diagnosed Uterine Leiomyosarcoma
Conditions: Leiomyosarcoma;   Uterine Neoplasm
Intervention: Drug: Letrozole
15 Completed Sunitinib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Conditions: Recurrent Uterine Sarcoma;   Uterine Leiomyosarcoma
Intervention: Drug: sunitinib malate
16 Active, not recruiting
Has Results
Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Alisertib;   Other: Laboratory Biomarker Analysis
17 Active, not recruiting
Has Results
Ixabepilone in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus Previously Treated With Chemotherapy
Conditions: Recurrent Uterine Corpus Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Drug: Ixabepilone;   Other: Laboratory Biomarker Analysis
18 Recruiting Gemcitabine Hydrochloride and Docetaxel Followed by Doxorubicin Hydrochloride or Observation in Treating Patients With High-Risk Uterine Leiomyosarcoma Previously Removed by Surgery
Conditions: Stage I Uterine Sarcoma;   Uterine Corpus Leiomyosarcoma
Interventions: Other: Clinical Observation;   Drug: Docetaxel;   Drug: Doxorubicin Hydrochloride;   Biological: Filgrastim;   Drug: Gemcitabine Hydrochloride;   Biological: Pegfilgrastim
19 Completed Adjuvant Docetaxel Plus Gemcitabine in Patients With Completely Resected Leiomyosarcoma (LMS) of the Uterus
Conditions: Uterine Leiomyosarcoma;   Uterine Cancer
Intervention: Drug: Docetaxel plus Gemcitabine
20 Not yet recruiting Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery
Conditions: Metastatic Leiomyosarcoma;   Metastatic Liposarcoma
Interventions: Drug: Avelumab;   Other: Laboratory Biomarker Analysis;   Drug: Trabectedin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.